{"id":"W2955662388","doi":"10.1200/jco.2019.37.15_suppl.7011","title":"Mutant IDH1 inhibitor ivosidenib (IVO; AG-120) in combination with azacitidine (AZA) for newly diagnosed acute myeloid leukemia (ND AML).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Gastroenterology; Leukocytosis; Adverse effect; Febrile neutropenia; Anemia; Hypokalemia; Nausea; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002744442,0.0002766438,0.0004886471,0.0001772973,0.0001517437,0.0002877989,0.0002931156,0.0001816329,0.001737048],"category_scores_gemma":[0.0002530359,0.0001255411,0.000204165,0.0001698002,0.000197533,0.0001328356,0.0002372692,0.0006867802,0.0003716879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005663554,"about_ca_system_score_gemma":0.0004578184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005315791,"about_ca_topic_score_gemma":0.002480741,"domain_scores_codex":[0.999877,0.00003652453,0.0000105102,0.00002450458,0.00002298607,0.00002854313],"domain_scores_gemma":[0.9998581,0.00001987426,0.00003287689,0.00001130509,0.000005532343,0.00007229776],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.09381776,0.01094388,0.07579529,0.0009919459,0.0007331452,0.00165874,0.0003946501,0.003180404,0.240667,0.0005190977,0.01025486,0.5610434],"study_design_scores_gemma":[0.05855712,0.3532854,0.3330318,0.0003301763,0.00136617,0.01168745,0.0002683686,0.007072026,0.1339346,0.0006983139,0.09969068,0.00007791963],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885201,0.005045821,0.0008881267,0.0002617316,0.00006658315,0.0003417493,0.0006104204,0.00006996445,0.004195442],"genre_scores_gemma":[0.9948342,0.001437034,0.001067698,0.0001413011,0.00004350229,0.0001037399,0.0008111774,0.000009621773,0.001551736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001737048,"threshold_uncertainty_score":0.005811036,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05347255513071011,"score_gpt":0.4111684294296463,"score_spread":0.3576958742989362,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}